English
Afrikaans
Albanian
Amharic
Arabic
Armenian
Azerbaijani
Basque
Belarusian
Bengali
Bosnian
Bulgarian
Catalan
Cebuano
Chichewa
Chinese (Simplified)
Chinese (Traditional)
Corsican
Croatian
Czech
Danish
Dutch
Esperanto
Estonian
Filipino
Finnish
French
Frisian
Galician
Georgian
German
Greek
Gujarati
Haitian Creole
Hausa
Hawaiian
Hebrew
Hindi
Hmong
Hungarian
Icelandic
Igbo
Indonesian
Irish
Italian
Japanese
Javanese
Kannada
Kazakh
Khmer
Korean
Kurdish (Kurmanji)
Kyrgyz
Lao
Latin
Latvian
Lithuanian
Luxembourgish
Macedonian
Malagasy
Malay
Malayalam
Maltese
Maori
Marathi
Mongolian
Myanmar (Burmese)
Nepali
Norwegian
Pashto
Persian
Polish
Portuguese
Punjabi
Romanian
Russian
Samoan
Scottish Gaelic
Serbian
Sesotho
Shona
Sindhi
Sinhala
Slovak
Slovenian
Somali
Spanish
Sudanese
Swahili
Swedish
Tajik
Tamil
Telugu
Thai
Turkish
Ukrainian
Urdu
Uzbek
Vietnamese
Welsh
Xhosa
Yiddish
Yoruba
Zulu
PIPELINE
AND RESOURCES
#KICKMSA #DefeatMSA #MSA #MSAawareness #WeRememberMSA #MSAAngels
Click on any drug in the interactive pipeline below to learn more about drugs in development or already in use by patients.
-
Anti-Inflammatory Therapies Learn more ›
- Not Applicable
- Phase One
- Phase Two
- Phase Three
- Phase Four
- To Patients
-
Alpha-Synuclein Targeting Therapies Learn more ›
- Not Applicable
- Phase One
- Phase Two
- Phase Three
- Phase Four
- To Patients
- Affitope(R) PD01A › : To Patients ›
- Sirolimus› : To Patients ›
- FTY 720 (Fingolimod)› : To Patients ›
- Belnacasan (VX-765)› : To Patients ›
- SynuClean-D› : To Patients ›
- Kallikrein-6› : To Patients ›
- MPLA› : To Patients ›
- BIIB101› : To Patients ›
- Lu AF82422 (alpha-synuclein mAb)› : To Patients ›
- ATH434 (formerly, PBT434 -Alterity Therapeutics)› : To Patients ›
- NBMI› : To Patients ›
- TAK-341› : To Patients ›
-
Neuroprotective Therapies Learn more ›
- Not Applicable
- Phase One
- Phase Two
- Phase Three
- Phase Four
- To Patients
- Intranasal insulin (INI) › : To Patients ›
- Stearoyl-CoA desaturase inhibition› : To Patients ›
- Verdiperstat (BHV-3241) › : To Patients ›
- BNN-20 › : To Patients ›
- Exenatide› : To Patients ›
- Gene therapy (AAV2-GDNF)› : To Patients ›
- Inosine 5-monophosphate› : To Patients ›
- Ubiquinol› : To Patients ›
- Stem cells› : To Patients ›
-
Diagnosis & Biomarkers Learn more ›
- Not Applicable
- Phase One
- Phase Two
- Phase Three
- Phase Four
- To Patients
- Alpha-synuclein› : To Patients ›
- Neuroimaging› : To Patients ›
- Alzheimer’s disease biomarkers› : To Patients ›
- Natural history study› : To Patients ›
- Brain network activation› : To Patients ›
- [18F]F-DOPA imaging› : To Patients ›
- Digital speech analysis (Voice4PD-MSA)› : To Patients ›
- Gait analysis› : To Patients ›
- Magnetic resonance imaging (MRI)› : To Patients ›
- Brain scans› : To Patients ›
- DaTSCAN™ Ioflupane (123l) injection/SPECT imaging› : To Patients ›
- MorphomerTM library PET tracer specific for alpha synuclein› : To Patients ›
- Transcranial magnetic stimulation (TMS)› : To Patients ›
- Web-based automated imaging (MRI)› : To Patients ›
-
Symptomatic Treatments Learn more ›
- Not Applicable
- Phase One
- Phase Two
- Phase Three
- Phase Four
- To Patients
- Ampreloxetine/TD-9855› : To Patients ›
- Atomoxetine› : To Patients ›
- Swallowing therapy› : To Patients ›
- Expiratory muscle strength training (EMST)› : To Patients ›
- Zoledronic acid › : To Patients ›
- NDMA modulator › : To Patients ›
- Safinamide› : To Patients ›
- Botulinum A toxin› : To Patients ›
- Riluzole› : To Patients ›
- Fipamezole (JP-1730)› : To Patients ›
- Droxidopa› : To Patients ›
- Midodrine and droxidopa› : To Patients ›
- Nebivolol› : To Patients ›
- Midodrine› : To Patients ›
- Deep brain stimulation (DBS) and spinal cord stimulation (SCS)› : To Patients ›
- Transcranial direct current stimulation (tDCS)› : To Patients ›
- Abdominal binder› : To Patients ›
- Continuous positive airway pressure (CPAP) › : To Patients ›
- Brain computer interface› : To Patients ›
- Spinal cord stimulation (SCS)› : To Patients ›
- Deep brain stimulation (DBS)› : To Patients ›
- Repetitive transcranial magnetic stimulation (rTMS) and physical therapy› : To Patients ›
- Transcranial magnetic stimulation (TMS)› : To Patients ›
Stay connected with research, register on our hub:
https://defeatmsa.org/research-registry/
Please help us advocate for more therapies, donate.
DISCLAIMER: Always consult with your physician or healthcare provider team for medical advice that pertains to you. Never disregard or delay seeking medical advice due to something that you have read on our website.
LOOKING FOR OTHER WAYS TO GET INVOLVED?
JOIN THE MOVEMENT TO #DEFEATMSA
Follow us on social media
Follow us on Twitter
Follow us on Facebook
Follow us on Instagram
Follow us on YouTube
Follow us on LinkedIn
Follow us on social media
Follow us on Twitter
Follow us on Facebook
Follow us on Instagram
Follow us on YouTube
Follow us on LinkedIn
Blogs & Downloadables
Overview MSA Treatments (EN)
Overview MSA Treatments (SP)
MSA Virtual Conference Flyer
Virtual Conference Booklet (2021)
MSA Awareness Card
Medical Resources
Researcher & Mission Blogs
MSA Patient Pamphlet
Defeat MSA Alliance Brochure
MSA Patient Wallet Card
Download Zoom MSA Backgrounds
